Fig. 7From: Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in ratsMetabolic biomarkers changes and related metabolic pathways involved in the treatment of HG/[6]-GR on CHF induced by DOX. a The metabolic pathways involved in the therapeutic effects of HG/[6]-GR on CHF; b The cluster heatmap of potential metabolites among groups. 1. Acetylphosphate; 2. 3-carboxy-1-hydroxypropylthiamine diphosphate; 3. coenzyme A; 4. palmitic acid; 5. PE(O-18:1(1Z)/20:4(5Z,8Z,11Z,14Z)); 6. oleic acid; 7. lysoPC(18:1(9Z)); 8. PC(16:0/16:0); c Relationship among the metabolic biomarkers and metabolic pathwaysBack to article page